FDA Approves Dectomax-CA1 for Prevention and Treatment of New World Screwworm

ZISK
Oct 1
1 min read

Today, the U.S. Food and Drug Administration conditionally approved Dectomax-CA1 (doramectin injection) injectable solution for the prevention and treatment of New World screwworm larval infestations, and prevention of NWS reinfestation for 21 days.

According to Zoetis, this conditional approval applies to beef cattle, female dairy cattle less than 20 months of age, pregnant beef cows, newborn calves and bulls.

“We understand the urgency with which America’s farmers and ranchers are asking for tools to fight New World screwworm,” says FDA Commissioner Marty Makary, M.D., M.P.H. in a press release. “Today’s conditional approval – the first in the U.S. for NWS – shows our dedication to rapidly advancing important animal medicines when they are needed most. We continue to work tirelessly to complete review of other NWS products to protect multiple animal species in the U.S.”

Click here to continue reading